Sign Up to like & get
recommendations!
0
Published in 2017 at "Gene Therapy"
DOI: 10.1038/gt.2017.21
Abstract: Ex vivo gene transfer to the graft before transplantation is an attractive option for circumventing systemic side effects of chronic antirejection therapy. Gene delivery of the immunomodulatory protein cytotoxic T-lymphocyte-associated protein 4–immunoglobulin (CTLA4-Ig) prevented chronic…
read more here.
Keywords:
non human;
kidney non;
mediated engineering;
human primates ... See more keywords